EHMT2-mediated transcriptional reprogramming drives neuroendocrine transformation in non-small cell lung cancer.
- DOI
- 10.1073/pnas.2317790121
- Published
- 2024 Jun 4
- Container
- Proceedings of the National Academy of Sciences of the United States of America
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1073/pnas.2317790121,
title = {EHMT2-mediated transcriptional reprogramming drives neuroendocrine transformation in non-small cell lung cancer.},
author = {Yang C and Ma S and Zhang J and Han Y and Wan L and Zhou W and Dong X and Yang W and Chen Y and Gao L and Cui W and Jia L and Yang J and Wu C and Wang Q and Wang L},
year = {2024},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
doi = {10.1073/pnas.2317790121},
url = {https://doi.org/10.1073/pnas.2317790121}
}RIS
TY - JOUR TI - EHMT2-mediated transcriptional reprogramming drives neuroendocrine transformation in non-small cell lung cancer. AU - Yang C AU - Ma S AU - Zhang J AU - Han Y AU - Wan L AU - Zhou W AU - Dong X AU - Yang W AU - Chen Y AU - Gao L AU - Cui W AU - Jia L AU - Yang J AU - Wu C AU - Wang Q AU - Wang L PY - 2024 JO - Proceedings of the National Academy of Sciences of the United States of America DO - 10.1073/pnas.2317790121 UR - https://doi.org/10.1073/pnas.2317790121 ER -
APA
C, Y., S, M., J, Z., Y, H., L, W., W, Z., X, D., W, Y., Y, C., L, G., W, C., L, J., J, Y., C, W., Q, W., & L, W. (2024). EHMT2-mediated transcriptional reprogramming drives neuroendocrine transformation in non-small cell lung cancer.. Proceedings of the National Academy of Sciences of the United States of America. https://doi.org/10.1073/pnas.2317790121
Source records
- pubmed · retrieved 2026-09-26T23:34:59.290Z
- europe-pmc · retrieved 2026-09-26T23:34:59.294Z